Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 13, 2013
Reporting Period: Quarter ended March 31, 2013
This filing serves as a notification that the Company issued a press release regarding its financial results for the first quarter of 2013. The detailed results are contained in Exhibit 99.1, which is incorporated by reference but not reproduced in the text of this 8-K.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1).
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative financial analysis.
Guidance, Outlook, and Risks
- Conference Call: The Company announced a conference call to review financial results and provide business updates. The text notes a call scheduled for March 13, 2013, which appears to be a discrepancy in the source text relative to the May 13, 2013 report date.
- Forward-Looking Statements: The filing contains forward-looking statements regarding plans, strategies, and intentions. These are subject to risks and uncertainties.
- Risk Factors: Specific risks are referenced in Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012.
- Legal Disclaimer: Information in Item 2.02 is "furnished" and not "filed" under Section 18 of the Exchange Act, limiting liability for the forward-looking statements contained therein.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 13, 2013) for actual Q1 2013 financial figures.
- Verify the correct date and time for the conference call, as the text mentions a March 13 date which conflicts with the May 13 filing date.
- Consult the Form 10-K filed on March 15, 2013, for detailed risk factors.
- Confirm the Company's cash position and burn rate, as these are not explicitly stated in the 8-K text.